Document is current
Any future updates will be listed below
-
Authors
Suzuki, Hiroyuki https://orcid.org/0000-0003-2383-5038
Ng, Cheng Han https://orcid.org/0000-0002-8297-1569
Tan, Darren Jun Hao
Teng, Margaret
Kawaguchi, Takumi https://orcid.org/0000-0002-7064-4325
Huang, Daniel Q.
- License Information
-
More Information
Article History
Accepted: 12 July 2023
First Online: 18 July 2023
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Cheng Han Ng has serves as a consultant for the Boxer Capital. Takumi Kawaguchi received lecture fee from the Janssen Pharmaceutical K.K., Taisho Pharmaceutical Co., Ltd., Kowa Company, Ltd., Otsuka Pharmaceutical Co., Ltd., Eisai Co., Ltd., ASKA Pharmaceutical Co., Ltd., AbbVie GK., and EA Pharma Co., Ltd. Daniel Q. Huang has served as an advisory board member for Eisai and receives funding support from the Singapore Ministry of Health’s National Medical Research Council under its NMRC Research Training Fellowship (MOH-000595-01). The rest of the authors have no conflicts of interest to declare.
